Discounted Cash Flow (DCF) Analysis Unlevered

Cano Health, Inc. (CANO)

$8.705

+0.03 (+0.40%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 8.705 | undervalue

Operating Data

Year
A/P
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue -------
Revenue (%)
EBITDA -------
EBITDA (%)
EBIT -------
EBIT (%)
Depreciation -------
Depreciation (%)

Balance Sheet Data

Year
A/P
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash -------
Total Cash (%)
Account Receivables -------
Account Receivables (%)
Inventories -------
Inventories (%)
Accounts Payable -------
Accounts Payable (%)
Capital Expenditure -------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 8.705
Beta 1.557
Diluted Shares Outstanding 170.87
Cost of Debt
Tax Rate -0.01
After-tax Cost of Debt -4,852.73%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.151
Total Debt 1.06
Total Equity 1,487.44
Total Capital 1,488.49
Debt Weighting 0.07
Equity Weighting 99.93
Wacc

Build Up Free Cash

Year
A/P
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue -------
EBITDA -------
EBIT -------
Tax Rate 0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
EBIAT -------
Depreciation -------
Accounts Receivable -------
Inventories -------
Accounts Payable -------
Capital Expenditure -12.07-34.35-----
UFCF -------
WACC
PV UFCF -------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 7.70
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt 0.89
Equity Value -
Shares Outstanding 170.87
Equity Value Per Share -